Postmenopausal Breast Cancer
Breast cancer is a serious threat to women of all ages. The incidence of breast cancer in women with severe obesity and central fat accumulation after menopause increases significantly. Taking estrogen after perimenopause can increase the chance of breast cancer, and high levels of prolactin can also increase the incidence of breast cancer.
-
Site of disease:
Breast Ovaries -
Infectious :
Not contagious -
Frequent population:
Menopausal women -
Related symptoms:
Related Drugs
Tamoxifen citrate oral solution
Indication: Anti-tumor drug used for advanced breast cancer in postmenopausal women.
Manufacturer:
Jilin Tianlitai Pharmaceutical Co., Ltd.
Chloroquine Capsules
Indication: Treatment of breast cancer, non-small cell lung cancer, etc.
Manufacturer:
Tonghua Mao Xiang Pharmaceutical Co., Ltd.
Tamoxifen Citrate Tablets
Indication: 1. To treat recurrent and metastatic breast cancer in women; 2. To be used as an adjuvant treatment for metastatic breast cancer after surgery to prevent recurrence.
Manufacturer:
Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd.
Related Ingredients
-
Tamoxifen list
15917-50-7 -
Tamoxifen citrate list
54965-24-1